{
    "name": "imiglucerase",
    "comment": "Rx",
    "other_names": [
        "Cerezyme"
    ],
    "classes": [
        "Enzymes",
        "Metabolic"
    ],
    "source": "https://reference.medscape.com/drug/cerezyme-imiglucerase-342844",
    "pregnancy": {
        "common": [
            "Published observational studies and case reports with use in pregnant females have not identified a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes",
            "No animal reproduction studies have been conducted"
        ],
        "specific": [
            {
                "type": "Pregnancy exposure registry",
                "description": [
                    "Monitors pregnancy outcomes in females during pregnancy",
                    "Encourage pregnant females exposed to drug to contact the Gaucher patient registry at 1-800-745-4447, extension 15500 or visit "
                ]
            },
            {
                "type": "Disease-associated maternal and/or embryofetal risk",
                "description": [
                    "Pregnancy may exacerbate existing Type 1 Gaucher disease symptoms or result in new disease manifestations",
                    "Untreated symptomatic Type 1 Gaucher may lead to complications during pregnancy, including hepatosplenomegaly, which can interfere with the normal growth of a pregnancy and thrombocytopenia, which can lead to excessive bleeding"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Available published literature suggests a small amount of imiglucerase is present in breast milk immediately following an infusion",
            "Published case reports and postmarketing reports of breastfed infants have not reported adverse effects due to Cerezyme exposure",
            "There are no data available on the effects on milk production"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None listed in the manufacturer's label"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Antibodies to imiglucerase that may lead to infusion reactions reported in up to 15% of patients within 6 months from the onset of therapy; antibody formation rare after 12 months of therapy",
                "Most patients with infusion reactions are able to continue treatment if pre-treated with antihistamines and/or corticosteroids and infused at a lower rate"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "miglustat",
            "description": {
                "common": "miglustat decreases levels of imiglucerase by increasing renal clearance. Use Caution/Monitor. Effects on imiglucerase levels variable; concomitant use not recommended by mfr of miglustat (Zavesca)."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Tachycardia",
            "percent": null
        },
        {
            "name": "Cyanosis",
            "percent": null
        },
        {
            "name": "Flushing",
            "percent": null
        },
        {
            "name": "Hypotension",
            "percent": null
        },
        {
            "name": "Cough",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "Pneumonia",
            "percent": null
        },
        {
            "name": "Pulmonary hypertension",
            "percent": null
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Vomiting",
            "percent": null
        },
        {
            "name": "Anaphylaxis",
            "percent": null
        },
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Back pain",
            "percent": null
        },
        {
            "name": "Chest discomfort",
            "percent": null
        },
        {
            "name": "Chills",
            "percent": null
        },
        {
            "name": "Fatigue",
            "percent": null
        },
        {
            "name": "Infusion",
            "percent": null
        },
        {
            "name": "site burning",
            "percent": null
        },
        {
            "name": "Infusion",
            "percent": null
        },
        {
            "name": "site discomfort",
            "percent": null
        },
        {
            "name": "Infusion",
            "percent": null
        },
        {
            "name": "site swelling",
            "percent": null
        },
        {
            "name": "Pyrexia",
            "percent": null
        }
    ]
}